Idioma:

Heart Disorders and Diseases; Study Data from M. Scaglione and Colleagues Update Understanding of Atrial Fibrillation [Pulmonary vein isolation with a new multipolar irrigated radiofrequency ablation catheter (nMARQTM): feasibility, acute and short-term efficacy, safety, ...]

Obesity, Fitness & Wellness Week, 2015, p.1127

Texto completo disponível

Citações Citado por

Título:
Heart Disorders and Diseases; Study Data from M. Scaglione and Colleagues Update Understanding of Atrial Fibrillation [Pulmonary vein isolation with a new multipolar irrigated radiofrequency ablation catheter (nMARQTM): feasibility, acute and short-term efficacy, safety, ...]
É parte de: Obesity, Fitness & Wellness Week, 2015, p.1127
Descrição: The news reporters obtained a quote from the research, "Aim of our study was to assess feasibility, acute and short-term success and safety of PVI by the use of this new technology with particular regard to the incidence of postablation silent cerebral ischemia (SCI). Twenty-five patients (76% males; age 57 +- 13 years) with paroxysmal AF underwent PVI using the nMARQTM catheter. PVI, confirmed by Lasso catheter mapping, was achieved in 100 out of 102 pulmonary veins (98%) identified, and final PVI was obtained in 24 out of 25 (96%) patients. The overall concordance between Lasso and nMARQTM signals in demonstrating PVI was 78%. No major procedural complications occurred and no patient suffered SCI, on the basis of cerebral magnetic resonance imaging performed before and after the procedure. Following a 6-month follow-up, 17/25 (68%) patients remained free from AF without antiarrhythmic drugs. In our preliminary experience, PVI with nMARQTM catheter appears to be feasible and safe, without incidence of SCI."
Editor: Atlanta: NewsRx
Idioma: Inglês

Voltar para lista de resultados

Buscando em bases de dados remotas. Favor aguardar.